3rd Quarter - Report

BUCHANAN INGERSOLL & ROONEY PC for AIM IMMUNOTECH INC.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. FY 2023 Appropriations for Defense Department, and National Institutes of Health (NIH). Work with Department of Defense on Ebola countermeasures.

LobbyistCovered position, as disclosed
KYLE A DARBY New —
EDWARD HILD Chief of Staff, Sen. Lisa Murkowski; Deputy Chief of Staff, Sen. Pete Domenici
MICHAEL P STRAZZELLA —
JAMES C WILTRAUT —

Contacted: Navy, Dept of; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Defense, Dept of (DOD)

Pharmacy PHA

Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. FY 2023 Appropriations for Defense Department, and National Institutes of Health (NIH). Work with Department of Defense on Ebola countermeasures.

LobbyistCovered position, as disclosed
KYLE A DARBY New —
EDWARD HILD Chief of Staff, Sen. Lisa Murkowski; Deputy Chief of Staff, Sen. Pete Domenici
MICHAEL P STRAZZELLA —
JAMES C WILTRAUT —

Contacted: SENATE; Food & Drug Administration (FDA); Defense, Dept of (DOD); Navy, Dept of; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.